From Heartbreak to Breakthrough
Mark Mamula, a professor of medicine at Yale School of Medicine, never planned to develop a cancer vaccine for dogs. His research focused on autoimmune diseases like lupus and Type 1 diabetes. But when his own dog died of inoperable cancer about 11 years ago, the loss planted a seed. A chance meeting with veterinary oncologist Gerry Post made him realise that the leap from human to canine cancer research was not as far as he had imagined.
Around one in four dogs will develop cancer during their lifetime, and for dogs over 10 years old, that number jumps to one in two. Yet effective treatments have remained limited for decades. Mamula's work on how the immune system attacks the body's own tissues gave him a unique insight — if the immune system could be guided to attack tumour cells, it might offer a powerful new weapon. This kind of innovative thinking is similar to the way researchers discovered that honeybee venom shows promise in fighting breast cancer — nature-inspired science tackling one of medicine's biggest challenges.
How the Vaccine Works
Many cancers in both dogs and humans overexpress proteins called EGFR and HER2, which fuel tumour growth. Existing treatments use monoclonal antibodies that bind to one part of these proteins, but patients can develop resistance over time. Mamula's team took a different approach, developing a vaccine that triggers a polyclonal immune response — creating antibodies from multiple immune cells that can bind to multiple parts of the tumour proteins simultaneously.
The result is a treatment that is harder for cancer to outsmart. After successful tests in mice, the team launched their first clinical trial in dogs in 2016, led by researchers Hester Doyle and Renelle Gee from Mamula's Yale lab.
A Search-and-Rescue Dog Named Hunter
One of the vaccine's most remarkable success stories is Hunter, an 11-year-old golden retriever who spent years as a search-and-rescue dog with his owner, Deana Hudgins. Hunter aided in hundreds of searches across the United States, including the devastating condominium collapse in Surfside, Florida in 2021. In 2022, he was diagnosed with osteosarcoma — a bone cancer that kills upwards of 65 percent of dogs within 12 months.
Hudgins opted for amputation and chemotherapy, but she also connected with Mamula through a former Navy SEAL studying at Yale. Hunter received the vaccine as part of a clinical trial. Twenty-two months after his diagnosis, he is now considered a long-term osteosarcoma survivor — running, swimming, and chasing other dogs with the same scrappy energy he had as a puppy. It is the kind of story that proves courage comes in all forms, much like a former teacher's inspiring fight against cancer with immunotherapy.
"We ask a lot of our working dogs. They work in environments that are very dangerous and often deadly. My promise to all of them is I will do whatever I have to do to give them the best, healthiest, longest life possible."
— Deana Hudgins, Hunter's Owner
Hundreds of Dogs and Counting
To date, more than 300 dogs have been treated with the vaccine across clinical trials at 11 sites in the United States and one in Canada. The results show that the treatment increases 12-month survival rates from about 35 percent to 60 percent for dogs with certain cancers, and for many dogs, it also shrinks tumours.
The vaccine is currently under review by the U.S. Department of Agriculture, and Mamula has created a company called TheraJan to eventually produce and distribute it. Once approved, the vaccine will always be free of charge for working dogs like Hunter. The bond between humans and their dogs is one of the most powerful in nature — not unlike the extraordinary lives of hummingbirds, these small creatures remind us that size has nothing to do with the impact you leave on the world.
"This vaccine is truly revolutionary. I couldn't be more excited to be a veterinary oncologist."
— Dr. Gerry Post, Veterinary Oncologist
Sources:
Yale News Staff. "Novel Cancer Vaccine Offers New Hope for Dogs — and Those Who Love Them." Yale News, 5 Mar. 2024. https://news.yale.edu/2024/03/05/novel-cancer-vaccine-offers-new-hope-dogs-and-those-who-love-them
Share a Pebble

Send a Pebble








